International Medicine and Health Guidance News ›› 2023, Vol. 29 ›› Issue (7): 929-931.DOI: 10.3760/cma.j.issn.1007-1245.2023.07.009

• Scientific Research • Previous Articles     Next Articles

Clinical value of MRI combined with CT in the diagnosis of mixed hepatic angiomyolipoma

Mou Renqi, Wang Chunye, Lan Shouchang, Zhang Yafei, Dong Ning   

  1. Imaging Department, Yantaishan Hospital of Yantai City, Yantai 264001, China

  • Received:2022-12-09 Online:2023-04-01 Published:2023-04-28
  • Contact: Mou Renqi, Email: qichihanfeng@163.com
  • Supported by:

    Natural Science Foundation of Shandong Province (ZR2019PH113)

MRI联合CT诊断混合型肝脏血管平滑肌脂肪瘤的临床价值

牟仁琪  王春业  兰受昌  张亚飞  董宁   

  1. 烟台市烟台山医院影像科,烟台 264001

  • 通讯作者: 牟仁琪,Email:qichihanfeng@163.com
  • 基金资助:

    山东省自然科学基金面上项目(ZR2019PH113

Abstract:

Objective To explore the clinical diagnostic value of magnetic resonance imaging (MRI) combined with CT in mixed hepatic angiomyolipoma (HAML). Methods The clinical data of 85 mixed HAML patients, including 34 males and 51 females, with an age of (52.37±7.48) years old, were retrospectively selected from Yantaishan Hospital of Yantai City from August 2019 to May 2022. All the patients underwent MRI and CT examinations after admission. The detection rates of the three examination modalities (MRI, CT, and MRI combined with CT examinations) were compared by χ2 test. Results The detection rate of MRI combined with CT was 98.82% (84/85), which was significantly higher than that of MRI [90.59% (77/85)] and CT [88.24% (75/85)] (both P<0.05). There was no statistically significant difference in the detection rate between MRI and CT (P>0.05). Conclusion The combination of MRI and CT in the clinical diagnosis of mixed HAML has a higher detection rate, better diagnostic efficacy, and better clinical application value.

Key words:

Mixed hepatic angiomyolipoma, MRI, CT

摘要:

目的 探究磁共振成像(magnetic resonance imagingMRI)联合CT检查对混合型肝脏血管平滑肌脂肪瘤(hepatic angiomyolipomaHAML)的临床诊断价值。方法 回顾性选取烟台市烟台山医院20198月至20225月间收治的85例混合型HAML患者的临床资料,其中男性34例,女性51例,年龄为(52.37±7.48)岁。患者入院后均进行MRICT检查。用χ2检验比较MRICTMRI联合CT检查3种检查方式的检出率。结果 MRI联合CT检查检出率为98.82%84/85),明显高于MRI90.59%77/85)和CT88.24%75/85)(均P<0.05);MRICT检出率比较差异无统计学意义(P>0.05)。结论 MRICT联合检查用于混合型HAML的临床诊断,检出率较高,诊断效能较好,具有较好临床应用价值。

关键词:

混合型肝脏血管平滑肌脂肪瘤, MRI, CT